EGFR and non-small cell lung carcinoma: The 18 hits were evaluated in four additional EGFR mutant NSCLC lines, and, of those 18, only 6 (CRKL, SRC, RAF1, FRK, BLK, and HCK) universally rescued EGFR dependence, while the rest of the hits varied in effect across the cell line panel.